BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND EBF1, COE1, 1879, ENSG00000164330, Q9UH73, OLF1, O/E-1, EBF AND Diagnosis
17 results:

  • 1. Association of long-term particulate matter exposure with all-cause mortality among patients with ovarian cancer: A prospective cohort.
    Li YZ; Huang SH; Shi S; Chen WX; Wei YF; Zou BJ; Yao W; Zhou L; Liu FH; Gao S; Yan S; Qin X; Zhao YH; Chen RJ; Gong TT; Wu QJ
    Sci Total Environ; 2023 Aug; 884():163748. PubMed ID: 37120017
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Pre-diagnosis fiber : carbohydrate intake ratio and mortality of ovarian cancer: results from a prospective cohort study.
    Liu FH; Du ZD; Li XY; Wei YF; Wen ZY; Yan S; Sun ML; Qin X; Gao S; Gong TT; Wu QJ
    Food Funct; 2022 Oct; 13(19):10046-10054. PubMed ID: 36093635
    [No Abstract]    [Full Text] [Related]  

  • 3. Association between pre-diagnostic dietary pattern and survival of ovarian cancer: Evidence from a prospective cohort study.
    Wen ZY; Liu C; Liu FH; Wei YF; Xu HL; Wang R; Li XY; Li YZ; Yan S; Qin X; Gao S; Li XQ; Zhao YH; Gong TT; Wu QJ
    Clin Nutr; 2022 Feb; 41(2):452-459. PubMed ID: 35007814
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Ovarian primary primitive neuroectodermal tumor: a review of cases at PUMCH and in the published literature.
    Chao X; Bi Y; Li L
    Orphanet J Rare Dis; 2019 Jun; 14(1):147. PubMed ID: 31217017
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A Nondilated Main Pancreatic Duct Predicts Type 2 Autoimmune Pancreatitis: Comparative Study of Resected Pancreatic Head Masses.
    Peláez-Luna M; Medina-Campos C; Uscanga-Domínuez L; Hernandez-Calleros J; Chan-Nuñez C; Negrete E; Angeles A
    Digestion; 2020; 101(2):137-143. PubMed ID: 30759428
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Impact of early vs late postoperative radioiodine remnant ablation on final outcome in patients with low-risk well-differentiated thyroid cancer.
    Tsirona S; Vlassopoulou V; Tzanela M; Rondogianni P; Ioannidis G; Vassilopoulos C; Botoula E; Trivizas P; Datseris I; Tsagarakis S
    Clin Endocrinol (Oxf); 2014 Mar; 80(3):459-63. PubMed ID: 23895145
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Injectable and oral contraceptive use and cancers of the breast, cervix, ovary, and endometrium in black South African women: case-control study.
    Urban M; Banks E; Egger S; Canfell K; O'Connell D; Beral V; Sitas F
    PLoS Med; 2012; 9(3):e1001182. PubMed ID: 22412354
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Ectopic bone formation and extramedullary hematopoiesis in the thyroid gland: report of a case and literature review.
    Akbulut S; Yavuz R; Akansu B; Sogutcu N; Arikanoglu Z; Basbug M
    Int Surg; 2011; 96(3):260-5. PubMed ID: 22216706
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Incidence of second malignancies after external beam radiotherapy for clinical stage I testicular seminoma.
    Lewinshtein D; Gulati R; Nelson PS; Porter CR
    BJU Int; 2012 Mar; 109(5):706-12. PubMed ID: 21883828
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Silent corticotroph adenomas have unique recurrence characteristics compared with other nonfunctioning pituitary adenomas.
    Cho HY; Cho SW; Kim SW; Shin CS; Park KS; Kim SY
    Clin Endocrinol (Oxf); 2010 May; 72(5):648-53. PubMed ID: 19650787
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Epithelial ovarian cancer: testing the 'androgens hypothesis'.
    Olsen CM; Green AC; Nagle CM; Jordan SJ; Whiteman DC; Bain CJ; Webb PM;
    Endocr Relat Cancer; 2008 Dec; 15(4):1061-8. PubMed ID: 18772244
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Body size and risk of epithelial ovarian and related cancers: a population-based case-control study.
    Olsen CM; Nagle CM; Whiteman DC; Purdie DM; Green AC; Webb PM
    Int J Cancer; 2008 Jul; 123(2):450-456. PubMed ID: 18449887
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer.
    Brown AP; Chen J; Hitchcock YJ; Szabo A; Shrieve DC; Tward JD
    J Clin Endocrinol Metab; 2008 Feb; 93(2):504-15. PubMed ID: 18029468
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The influence of reproductive and hormonal factors on ovarian cancer survival.
    Nagle CM; Bain CJ; Green AC; Webb PM
    Int J Gynecol Cancer; 2008; 18(3):407-13. PubMed ID: 17645507
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Thyroid cancer and multiple primary tumors in the SEER cancer registries.
    Ronckers CM; McCarron P; Ron E
    Int J Cancer; 2005 Nov; 117(2):281-8. PubMed ID: 15880372
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Pregnancy recency and risk of ovarian cancer.
    Cooper GS; Schildkraut JM; Whittemore AS; Marchbanks PA
    Cancer Causes Control; 1999 Oct; 10(5):397-402. PubMed ID: 10530609
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Risk of second malignant neoplasms among long-term survivors of testicular cancer.
    Travis LB; Curtis RE; Storm H; Hall P; Holowaty E; Van Leeuwen FE; Kohler BA; Pukkala E; Lynch CF; Andersson M; Bergfeldt K; Clarke EA; Wiklund T; Stoter G; Gospodarowicz M; Sturgeon J; Fraumeni JF; Boice JD
    J Natl Cancer Inst; 1997 Oct; 89(19):1429-39. PubMed ID: 9326912
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.